[Immunotherapy in allergic diseases. Evaluation of short-term efficacy of aluminum hydroxide-absorbed slow-release preparations].
Clinical and immunological changes after immunotherapy (ITS) for respiratory allergy were evaluated in 29 subjects during a one year follow up period. No adverse effects were noted with alum-absorbed allergen extracts. However, only patients receiving ITS for grass pollens demonstrated clinical improvement and blocking IgG increase as compared with those with multiple allergen sensitivity.
Spinozzi
F
F
Istituto di Clinica Medica I, Università degli Studi di Perugia.
Cimignoli
E
E
Broccucci
L
L
Gerli
R
R
Cernetti
C
C
Rambotti
P
P
D000293:Adolescent; D000328:Adult; D000485:Allergens; D000536:Aluminum Hydroxide; D001249:Asthma / Q000628:therapy; D003888:Desensitization, Immunologic; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012130:Respiratory Hypersensitivity / Q000175:diagnosis / Q000628:therapy*; D012221:Rhinitis, Allergic, Perennial / Q000628:therapy; D006255:Rhinitis, Allergic, Seasonal / Q000628:therapy; D012882:Skin Tests
D000485:Allergens; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D000536:Aluminum Hydroxide
L'immunoterapia nelle malattie allergiche. Valutazione dell'efficacia a breve termine di preparati ritardo assorbiti su idrossido di alluminio.